Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer

NCT03196388 is registered in ClinicalTrials.gov with Fundación Canaria Instituto de Investigación Sanitaria de Canarias as lead sponsor.

NCT NCT03196388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03196388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer
Lead sponsor
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Phase
Phase 2
Overall status
Unknown status
Start date
December 27, 2017
Completion date
December 31, 2018
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate carcinoma